63,410 Shares in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Purchased by Virtu Financial LLC

Virtu Financial LLC acquired a new position in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 63,410 shares of the company’s stock, valued at approximately $72,000. Virtu Financial LLC owned about 0.38% of MIRA Pharmaceuticals at the end of the most recent reporting period.

Separately, International Assets Investment Management LLC bought a new stake in shares of MIRA Pharmaceuticals during the 4th quarter worth approximately $29,000. Hedge funds and other institutional investors own 35.16% of the company’s stock.

MIRA Pharmaceuticals Stock Down 7.5 %

Shares of MIRA Pharmaceuticals stock opened at $0.98 on Tuesday. The stock’s fifty day moving average is $1.12 and its two-hundred day moving average is $1.22. MIRA Pharmaceuticals, Inc. has a 52 week low of $0.51 and a 52 week high of $5.01. The company has a market capitalization of $16.23 million, a PE ratio of -1.75 and a beta of 2.31.

MIRA Pharmaceuticals (NASDAQ:MIRA) last posted its quarterly earnings results on Friday, March 28th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.14. As a group, research analysts anticipate that MIRA Pharmaceuticals, Inc. will post -0.6 earnings per share for the current year.

MIRA Pharmaceuticals Profile

MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.